Ticker: DOCS

Doximity

Healthcare Healthcare Medical - Healthcare Information Services
Price 20.42
Reco Sell Potential 30 Risk 70 Updated 2026-07-27

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell
Description

Company and Business Model

Doximity operates a digital platform for healthcare professionals, providing tools for communication, collaboration, and career development. Its core products include a professional network for physicians, telehealth services, and medical content. Major business segments encompass subscription services for healthcare organizations and advertising revenue from pharmaceutical companies. The primary revenue sources are membership fees and advertising.

Investment Profile

The investment profile of Doximity is more aligned with balanced investors, given its focus on both growth potential and the current market challenges. The stock exhibits moderate volatility and has shown a decline in revenue, indicating a cautious outlook. Investors may find it suitable for a medium-term horizon, with considerations for liquidity and experience levels.

Fundamental metrics (experimental) Updated: 2026-07-23
EPS (TTM) — earnings per share for the last 12 months, $
1.04
Revenue QoQ — quarter-over-quarter revenue growth
-21.4%
EPS surprise
-7.1%
20d volatility
2.3%
AI recommendation changes
Date Before After Reason
2026-06-03 Hold Sell Weak fundamentals and negative momentum raise significant concerns.
2026-05-08 Hold Positive revenue growth, but high volatility and risk.
2026-05-08 Sell Hold Компания Doximity показывает положительную динамику в краткосрочной перспективе, однако значительное падение за последние 120 дней и высокий риск делают её менее привлекательной для покупки в данный момент.
Analyst forecasts
Date Analyst Action Target Price Then
2026-05-14 Barclays Rating Downgraded — → 20 18.01
2026-05-14 Truist Financial Target Lowered 29 → 19 17.87
2026-05-14 BMO Capital Target Lowered 25 → 20 23.39
News Page 1 of 1

Nothing yet